Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
Status:
RECRUITING
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
The optimal anticoagulant for the treatment of left ventricular (LV) thrombus following acute myocardial infarction (AMI) is unclear. The aim of this multicenter randomized study is to evaluate the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with LV thrombus after AMI.
Phase:
PHASE4
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Karolinska Trial Alliance Stockholm County Council ALF/PPG Swedish Heart Lung Foundation The Swedish Research Council